Post-reproductive Health: Window of Opportunity for Preventing Comorbidities

Area of Science:

• Reproductive Endocrinology
• Geriatric Health
• Hormone Therapy Research

Background:

• Menopausal hormone therapy (MHT) use has fluctuated due to evolving risk-benefit perceptions.
• Comorbidity incidence increases post-menopause, necessitating preventative strategies.
• Past universal MHT use led to an unfavorable risk-benefit ratio, causing a significant decline in its application.

Discussion:

• The concept of a
• window of opportunity
• suggests MHT may be beneficial if initiated early post-menopause.
• This approach may mitigate risks and prevent menopause-associated comorbidities.
• Re-evaluating MHT's role in post-reproductive health is crucial.

Key Insights:

• MHT's risk-benefit profile is time-dependent.
• Early MHT initiation may prevent future health complications.
• Targeted MHT application can be safe and effective.

Outlook:

• Further research into the optimal timing and patient selection for MHT is warranted.
• Personalized MHT strategies could redefine post-reproductive healthcare.
• Focus on preventative comorbidity management in menopause is essential.